Lumateperone for the Prevention of Relapse in Patients With Schizophrenia
Clinical trial NCT04959032 · COMPLETED
Trial details
- NCT number
- NCT04959032
- Sponsor
- Intra-Cellular Therapies, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-08
- Primary completion
- 2024-07-25
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.